AGN.AX
Price:
$0.13
Market Cap:
$16.70M
Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Industry
Biotechnology
IPO Date
2021-06-11
Stock Exchange
ASX
Ticker
AGN.AX
According to Argenica Therapeutics Ltd’s latest financial reports and current stock price. The company's current ROE is -29.22%. This represents a change of -27.40% compared to the average of -40.25% of the last 4 quarters.
The mean historical ROE of Argenica Therapeutics Ltd over the last ten years is -338.95%. The current -29.22% ROE has changed -91.38% with respect to the historical average. Over the past ten years (40 quarters), AGN.AX's ROE was at its highest in in the June 2026 quarter at 41.53%. The ROE was at its lowest in in the June 2020 quarter at -2082.96%.
Average
-338.95%
Median
-49.24%
Minimum
-2084.05%
Maximum
-15.04%
Discovering the peaks and valleys of Argenica Therapeutics Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 227.48%
Maximum Annual ROE = -15.04%
Minimum Annual Increase = -99.28%
Minimum Annual ROE = -2084.05%
| Year | ROE | Change |
|---|---|---|
| 2026 | -23.13% | -76.65% |
| 2025 | -99.08% | 152.25% |
| 2024 | -39.28% | -37.46% |
| 2023 | -62.81% | 27.55% |
| 2022 | -49.24% | 227.48% |
| 2021 | -15.04% | -99.28% |
The current ROE of Argenica Therapeutics Ltd (AGN.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-53.83%
5-year avg
-54.71%
10-year avg
-338.95%
Argenica Therapeutics Ltd’s ROE is less than Noxopharm Limited (186.62%), greater than Prescient Therapeutics Limited (-44.93%), greater than BCAL Diagnostics Limited (-881.94%), greater than Microba Life Sciences Limited (-75.96%), greater than INOVIQ Ltd (-36.48%), greater than Nova Eye Medical Limited (-28.79%), greater than AnteoTech Limited (-71.28%), greater than Emyria Limited (-58.38%), greater than Immuron Limited (-31.88%), greater than Tissue Repair Ltd (-52.04%),
| Company | ROE | Market cap |
|---|---|---|
| 186.62% | $18.74M | |
| -44.93% | $69.40M | |
| -881.94% | $33.18M | |
| -75.96% | $36.57M | |
| -36.48% | $21.82M | |
| -28.79% | $38.46M | |
| -71.28% | $48.90M | |
| -58.38% | $24.06M | |
| -31.88% | $11.60M | |
| -52.04% | $5.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Argenica Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Argenica Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Argenica Therapeutics Ltd's ROE?
How is the ROE calculated for Argenica Therapeutics Ltd (AGN.AX)?
What is the highest ROE for Argenica Therapeutics Ltd (AGN.AX)?
What is the 3-year average ROE for Argenica Therapeutics Ltd (AGN.AX)?
What is the 5-year average ROE for Argenica Therapeutics Ltd (AGN.AX)?
How does the current ROE for Argenica Therapeutics Ltd (AGN.AX) compare to its historical average?